Role of 9p21 and 2q36 variants and arterial stiffness in the prediction of coronary artery disease

European Journal of Clinical Investigation

Volumn 44, Issue 8, 2014, Pages 784-794

  Vakalis, Konstantinos ^a   Bechlioulis, Aris ^a   Naka, Katerina K ^a   Chatzikyriakidou, Anthoula ^a   Gartzonika, Konstantina ^a   Vezyraki, Patra ^a   Kolios, Georgios ^b   Pappas, Konstantinos ^a   Katsouras, Christos S ^a   Georgiou, Ioannis ^a   Michalis, Lampros K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

2q36 polymorphisms; 9p21 polymorphisms; Arterial stiffness; Framingham risk score; Pulse wave velocity; Suspected stable coronary artery disease

Indexed keywords

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR RISK; CHROMOSOME 2Q; CHROMOSOME 2Q36; CHROMOSOME 9P; CHROMOSOME 9P21; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; FRAMINGHAM RISK SCORE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; PULSE WAVE; SINGLE NUCLEOTIDE POLYMORPHISM; TONOMETRY; CHROMOSOME 2; CHROMOSOME 9; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOMOZYGOTE; PROSPECTIVE STUDY; RISK FACTOR;

CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84904558899     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12295     Document Type: Article

References (45)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125:e2-220.
2. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91.
3. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007;357:443-53.
4. Franceschini N, Carty C, Buzkova P, Reiner AP, Garrett T, Lin Y et al. Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study. Circ Cardiovasc Genet 2011;4:661-72.
5. Dandona S, Stewart AF, Chen L, Williams K, So D, O'Brien E et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol 2010;56:479-86.
6. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008;40:217-24.
7. Matarin M, Brown WM, Singleton A, Hardy JA, Meschia JF. Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke 2008;39:1586-9.
8. Anderson JL, Horne BD, Kolek MJ, Muhlestein JB, Mower CP, Park JJ et al. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J 2008;156:1155-62 e2.
9. Patel RS, Su S, Neeland IJ, Ahuja A, Veledar E, Zhao J et al. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur Heart J 2010;31:3017-23.
10. Chan K, Motterle A, Laxton RC, Ye S. Common variant on chromosome 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol 2011;57:1497-8; author reply 8-9.
11. Chan K, Patel RS, Newcombe P, Nelson CP, Qasim A, Epstein SE et al. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. J Am Coll Cardiol 2013;61:957-70.
12. Chen SN, Ballantyne CM, Gotto AM Jr, Marian AJ. The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis. BMC Cardiovasc Disord 2009;9:3.
13. Lim S, Hong J, Liu CT, Hivert MF, White CC, Murabito JM et al. Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2013;229:149-54.
14. Karvanen J, Silander K, Kee F, Tiret L, Salomaa V, Kuulasmaa K et al. The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts. Genet Epidemiol 2009;33:237-46.
15. Arregui M, Fisher E, Knuppel S, Buijsse B, di Giuseppe R, Fritsche A et al. Significant associations of the rs2943634 (2q36.3) genetic polymorphism with adiponectin, high density lipoprotein cholesterol and ischemic stroke. Gene 2012;494:190-5.
16. Muendlein A, Saely CH, Rhomberg S, Sonderegger G, Loacker S, Rein P et al. Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease. Atherosclerosis 2009;205:174-80.
17. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-41.
18. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
19. Bechlioulis A, Vakalis K, Naka KK, Bourantas CV, Papamichael ND, Kotsia A et al. Increased aortic pulse wave velocity is associated with the presence of angiographic coronary artery disease in overweight and obese patients. Am J Hypertens 2012;26:265-70.
20. Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005;18:388-96.
21. Hope SA, Antonis P, Adam D, Cameron JD, Meredith IT. Arterial pulse wave velocity but not augmentation index is associated with coronary artery disease extent and severity: implications for arterial transfer function applicability. J Hypertens 2007;25:2105-9.
22. Alarhabi AY, Mohamed MS, Ibrahim S, Hun TM, Musa KI, Yusof Z. Pulse wave velocity as a marker of severity of coronary artery disease. J Clin Hypertens (Greenwich) 2009;11:17-21.
23. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31:1865-71.
24. Weber T, O'Rourke MF, Lassnig E, Porodko M, Ammer M, Rammer M et al. Pulse waveform characteristics predict cardiovascular events and mortality in patients undergoing coronary angiography. J Hypertens 2010;28:797-805.
25. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004;109:184-9.
26. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
28. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
29. Lee BC, Lee WJ, Hsu HC, Chien KL, Shih TT, Chen MF. Using clinical cardiovascular risk scores to predict coronary artery plaque severity and stenosis detected by CT coronary angiography in asymptomatic Chinese subjects. Int J Cardiovasc Imaging 2011;27:669-78.
30. Versteylen MO, Joosen IA, Shaw LJ, Narula J, Hofstra L. Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol 2011;18:904-11.
31. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012;30:445-8.
32. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Methodol 1995;57:289-300.
34. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007;316:1491-3.
35. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 2008;52:378-84.
36. Cesana F, Nava S, Menni C, Boffi L, Varrenti M, Meani P et al. Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals. Blood Press 2013;22:302-6.
37. Phababpha S, Kukongviriyapan U, Pakdeechote P, Senggunprai L, Kukongviriyapan V, Settasatian C et al. Association of arterial stiffness with single nucleotide polymorphism rs1333049 and metabolic risk factors. Cardiovasc Diabetol 2013;12:93.
38. Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang SJ et al. Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007;8(Suppl 1):S3.
39. Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A, Smith AV, Yasmin et al. Common genetic variation in the 3′-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet 2012;5:81-90.
40. Samani NJ, Raitakari OT, Sipila K, Tobin MD, Schunkert H, Juonala M et al. Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:1679-83.
41. Aschauer S, Mittermayer F, Wagner CC, Schmidt WM, Brunner M, Haslacher H et al. Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphism. Eur J Clin Invest 2010;40:700-5.
42. Cunnington MS, Mayosi BM, Hall DH, Avery PJ, Farrall M, Vickers MA et al. Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima-media thickness or intermediate risk phenotypes. Atherosclerosis 2009;203:41-4.
43. Calvet D, Touze E, Laurent S, Varenne O, Sablayrolles JL, Boutouyrie P et al. Aortic stiffness measurement improves the prediction of asymptomatic coronary artery disease in stroke/transient ischemic attack patients. Int J Stroke 2014;9:291-6.
44. Cho SW, Kim BK, Kim JH, Byun YS, Goh CW, Rhee KJ et al. Non-invasively measured aortic wave reflection and pulse pressure amplification are related to the severity of coronary artery disease. J Cardiol 2013;62:131-7.
45. Nambi V, Boerwinkle E, Lawson K, Brautbar A, Chambless L, Franeschini N et al. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2012;222:135-7.